Telmisartan Actavis
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Telmisartan Actavis, covering 2025-01-28 to 2026-07-07. Get the full timeline:
Most recent: EMA Authorised: Telmisartan Actavis (telmisartan) — Actavis Group PTC ehf